Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of 2011/2012 Influenza Vaccine in Adults and Elderly
NCT01357265Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2011
- Primary completion
- May 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ARCT-2138 in influenza, sponsored by Novartis. Started May 2011; status: completed.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01357265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357265.